LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION April 14, 2023 TO: Honorable Morgan Meyer, Chair, House Committee on Ways & Means FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB4901 by Bonnen (Relating to the exemption from ad valorem taxation of certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products.), As Introduced Estimated Two-year Net Impact to General Revenue Related Funds for HB4901, As Introduced : a negative impact of ($28,826,000) through the biennium ending August 31, 2025. General Revenue-Related Funds, Five- Year Impact: Fiscal Year Probable Net Positive/(Negative) Impact toGeneral Revenue Related Funds2024$02025($28,826,000)2026($33,299,000)2027($38,277,000)2028($41,147,000)All Funds, Five-Year Impact: Fiscal Year Probable Savings/(Cost) fromFoundation School Fund193 Probable Savings/(Cost) fromRecapture Payments Atten Crdts8905 Probable Revenue Gain/(Loss) fromSchool Districts2024$0$0$02025($28,826,000)$12,199,000($43,093,000)2026($33,299,000)$13,695,000($49,136,000)2027($38,277,000)$15,736,000($55,488,000)2028($41,147,000)$16,953,000($60,076,000) Fiscal AnalysisThe bill would amend Chapter 11 of the Tax Code, relating to Taxable Property and Exemptions, to provide a property tax exemption for certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products. The bill would add definitions and make conforming changes.The bill would take effect January 1, 2024, contingent on the approval by voters of a constitutional amendment authorizing the exemption (HJR 184).
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
April 14, 2023
TO: Honorable Morgan Meyer, Chair, House Committee on Ways & Means FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB4901 by Bonnen (Relating to the exemption from ad valorem taxation of certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products.), As Introduced
TO: Honorable Morgan Meyer, Chair, House Committee on Ways & Means
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB4901 by Bonnen (Relating to the exemption from ad valorem taxation of certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products.), As Introduced
Honorable Morgan Meyer, Chair, House Committee on Ways & Means
Honorable Morgan Meyer, Chair, House Committee on Ways & Means
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
HB4901 by Bonnen (Relating to the exemption from ad valorem taxation of certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products.), As Introduced
HB4901 by Bonnen (Relating to the exemption from ad valorem taxation of certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products.), As Introduced
Estimated Two-year Net Impact to General Revenue Related Funds for HB4901, As Introduced : a negative impact of ($28,826,000) through the biennium ending August 31, 2025.
Estimated Two-year Net Impact to General Revenue Related Funds for HB4901, As Introduced : a negative impact of ($28,826,000) through the biennium ending August 31, 2025.
General Revenue-Related Funds, Five- Year Impact:
2024 $0
2025 ($28,826,000)
2026 ($33,299,000)
2027 ($38,277,000)
2028 ($41,147,000)
All Funds, Five-Year Impact:
2024 $0 $0 $0
2025 ($28,826,000) $12,199,000 ($43,093,000)
2026 ($33,299,000) $13,695,000 ($49,136,000)
2027 ($38,277,000) $15,736,000 ($55,488,000)
2028 ($41,147,000) $16,953,000 ($60,076,000)
Fiscal Analysis
The bill would amend Chapter 11 of the Tax Code, relating to Taxable Property and Exemptions, to provide a property tax exemption for certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products. The bill would add definitions and make conforming changes.The bill would take effect January 1, 2024, contingent on the approval by voters of a constitutional amendment authorizing the exemption (HJR 184).
Methodology
The bill would, after approval of a constitutional amendment, exempt from property tax certain tangible personal property held or used by a manufacturer of medical or biomedical products. The property tax data available via the school district property value study are not industry specific.The Annual Survey of Manufacturing data on inventory and capital expenditures on machinery and equipment for the U.S. in pharmaceutical and medical manufacturing industries were adjusted using the ratio of Texas to US production employment for those industries to obtain representative data for Texas. Ratio of effective capital stock to capital expenditures for industrial production was used to estimate machinery and equipment exempt from sales and use tax under Sec. 151.318, and then reduced for depreciation to represent value on property tax rolls. As a result, taxable property value would be decrease which would represent a cost to the state through the school finance formulas.Under provisions of the Education Code, the school district tax revenue loss is partially transferred to the state. The cost to the Foundation School Program (FSP) due to exempting certain tangible personal property held by a manufacturer of medical or biomedical products as a finished good or used in the manufacturing or processing of medical or biomedical products is estimated to be $28.8 million in fiscal year 2025, increasing to $41.1 million in fiscal year 2028. The cost to the FSP includes estimated decreases in Recapture Payments - Attendance Credits of $12.2 million in fiscal year 2025, increasing to $17.0 million in fiscal year 2028 as a result of the reduction in school district taxable value. The decrease in recapture is reflected as a savings in the table above because recapture is appropriated as a method of finance for the FSP in the General Appropriations Act.
Local Government Impact
Contingent upon passage of a constitutional amendment authorizing the exemption, the bill would exempt from property tax certain tangible personal property held or used by a manufacturer of medical or biomedical products which could reduce taxable value. However, the no-new-revenue and voter-approval tax rates as provided by Section 26.04, Tax Code could be higher as a consequence of the additional exemption proposed by the bill.The fiscal impact to school districts is shown in the table above.
The fiscal impact to school districts is shown in the table above.
Source Agencies: b > td > 304 Comptroller of Public Accounts
304 Comptroller of Public Accounts
LBB Staff: b > td > JMc, KK, BRI, SD
JMc, KK, BRI, SD